Results 171 to 180 of about 11,492 (188)

Omalizumab

Reactions Weekly
  +4 more sources

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

Journal of Allergy and Clinical Immunology, 2001
William Busse
exaly  

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆

Journal of Allergy and Clinical Immunology, 2004
Calman Prussin, Thomas B Casale
exaly  

Omalizumab

Reactions Weekly, 2014
openaire   +2 more sources

Omalizumab-induced reductions in mast cell FcεRI expression and function

Journal of Allergy and Clinical Immunology, 2004
Donald MacGlashan Jr, Sarbjit Saini
exaly  

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Journal of Allergy and Clinical Immunology, 2011
Sarbjit Saini, Allen P Kaplan, Marcus Maurer   +2 more
exaly  

Omalizumab and the risk of malignancy: Results from a pooled analysis

Journal of Allergy and Clinical Immunology, 2012
William Busse, Janice Canvin
exaly  

Omalizumab

Nature Reviews Drug Discovery, 2004
exaly  

Omalizumab treatment downregulates dendritic cell FcεRI expression

Journal of Allergy and Clinical Immunology, 2003
Calman Prussin, Thomas B Casale
exaly  

Omalizumab

Reactions Weekly, 2010
openaire   +1 more source